Compare Gaudium IVF with Similar Stocks
Stock DNA
Healthcare Services
INR 549 Cr (Micro Cap)
29.00
55
0.00%
0.27
36.63%
12.09
Total Returns (Price + Dividend) 
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Closure of Trading Window
28-Mar-2026 | Source : BSEPursuant to the provisions of the Code on Prohibition of Insider Trading of Gaudium IVF and Women Health Limited (Company) and the SEBI PIT Regulations 2015 as amended from time to time we wish to inform you that the trading window for trading in shares of the Company will remain closed for all designated persons and their immediate relative(s) from Wednesday April 01 2026 till 48 hours after the declaration of financial results of the Company for the quarter and year ended March 31 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
19-Mar-2026 | Source : BSEPursuant to Regulation 47 of SEBI Listing Regulations 2015 copies of newspaper publication of Unaudited Financial Results for the quater & nine months ended December 31 2025 is attached herewith.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
19-Mar-2026 | Source : BSEPress Release on the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Feb 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 8 FIIs (9.24%)
Manika Khanna (70.73%)
Meru Investment Fund Pcc-cell 1 (2.96%)
13.52%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -38.17% vs 64.52% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -64.78% vs 169.55% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 12.98% vs 18.65% in Mar 2024
YoY Growth in year ended Mar 2025 is 11.96% vs 25.49% in Mar 2024






